Login / Signup

The value of the reflective discussion in decision-making using multi-criteria decision analysis (MCDA): an example of determining the value contribution of tabelecleucel for the treatment of the Epstein Barr virus-positive post-transplant lymphoproliferative disease (EBV + PTLD).

Xavier BadiaMiguel Ángel CallejaVicente Escudero-VilaplanaAntonio Pérez-MartínezJosé Luis PiñanaJosé Luis PovedaJoan-Antoni Vallès
Published in: Orphanet journal of rare diseases (2024)
The study shows that the MCDA methodology is a useful tool for decision-making on innovative treatments for the management of rare diseases. It also highlights the importance of reflective multidisciplinary discussion for its ability to resolve doubts or misinterpretations of experts, subsequently allowing to obtain more consistent and reliable results on the value contribution of the drug, being potentially more positive.
Keyphrases
  • epstein barr virus
  • decision making
  • diffuse large b cell lymphoma
  • emergency department
  • adverse drug
  • data analysis